a public good project by the
Synthesis
Company
of California

© 2026

Hironobu Ihn | doi.page

0 works0 citations0 h-index

Hironobu Ihn

Kumamoto University(JP)

Publications by Year

Research Areas

Systemic Sclerosis and Related Diseases, Dermatologic Treatments and Research, Inflammatory Myopathies and Dermatomyositis, Autoimmune Bullous Skin Diseases, Dermatological and Skeletal Disorders

Most-Cited Works

→ Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial(2020)621 cited
→ Characterization of SIS3, a Novel Specific Inhibitor of Smad3, and Its Effect on Transforming Growth Factor-β1-Induced Extracellular Matrix Expression(2005)444 cited
→ Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders(1996)436 cited
→ Pathogenesis of fibrosis: role of TGF-β and CTGF(2002)356 cited
→ Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment(2018)297 cited
→ Significant Correlation Between Connective Tissue Growth Factor Gene Expression and Skin Sclerosis in Tissue Sections from Patients with Systemic Sclerosis(1995)282 cited

→ Increased Expression of TGF-β Receptors by Scleroderma Fibroblasts: Evidence for Contribution of Autocrine TGF-β Signaling to Scleroderma Phenotype(1998)253 cited

→ A randomized double-blind trial of intravenous immunoglobulin for pemphigus(2009)250 cited

→ Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis(2010)241 cited

→ Increased Expression of Integrin αvβ3 Contributes to the Establishment of Autocrine TGF-β Signaling in Scleroderma Fibroblasts(2005)224 cited